Kei Moriya Selected Research

Steroids

10/2023	Trajectory analyses to identify persistently low responders to COVID-19 vaccination in patients with inflammatory bowel disease: a prospective multicentre controlled study, J-COMBAT.
1/2021	Chronic active EBV infection in refractory enteritis with longitudinal ulcers with a cobblestone appearance: an autopsied case report.
10/2008	Pneumatosis cystoides intestinalis following alpha-glucosidase inhibitor treatment: a case report and review of the literature.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kei Moriya Research Topics

Disease

40	Liver Cirrhosis (Hepatic Cirrhosis) 07/2023 - 07/2008
36	Fibrosis (Cirrhosis) 07/2023 - 12/2008
17	Hepatocellular Carcinoma (Hepatoma) 10/2023 - 07/2008
12	Neoplasms (Cancer) 01/2021 - 02/2007
11	Fatty Liver 12/2021 - 07/2013
9	Liver Diseases (Liver Disease) 05/2023 - 05/2013
8	Non-alcoholic Fatty Liver Disease 11/2021 - 02/2016
6	Inflammation (Inflammations) 12/2022 - 01/2013
6	Hepatic Encephalopathy 12/2021 - 07/2003
6	Alcoholic Fatty Liver 03/2019 - 07/2008
5	Infections 01/2022 - 05/2013
5	Insulin Resistance 08/2020 - 08/2013
4	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 12/2022 - 01/2017
4	Alcoholic Liver Diseases (Alcoholic Liver Disease) 12/2021 - 01/2013
4	Body Weight (Weight, Body) 01/2021 - 02/2007
4	Hyperammonemia 12/2020 - 12/2017
3	Autoimmune Hepatitis 07/2023 - 06/2021
3	Acute-On-Chronic Liver Failure 01/2023 - 05/2020
3	Ascites 05/2022 - 08/2017
3	Thrombophilia 03/2022 - 05/2019
3	Sarcopenia 03/2022 - 01/2020
3	Muscle Cramp (Cramp) 12/2020 - 01/2019
3	Chronic Hepatitis (Chronic Active Hepatitis) 01/2019 - 01/2018
2	Ulcerative Colitis 01/2024 - 12/2023
2	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 09/2021 - 07/2021
2	Dysbiosis 06/2021 - 01/2019
2	Cognitive Dysfunction 06/2021 - 03/2020
2	Lymphoma (Lymphomas) 01/2021 - 07/2012
2	Liver Neoplasms (Liver Cancer) 01/2021 - 01/2018
2	Cholangiocarcinoma 10/2020 - 10/2018
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2020 - 01/2019
2	Thrombocytopenia (Thrombopenia) 09/2020 - 01/2020
2	Hemorrhage 09/2020 - 01/2017
2	Thrombosis (Thrombus) 09/2020 - 08/2017
2	Chronic Hepatitis B 08/2020 - 09/2017
2	Hypertension (High Blood Pressure) 06/2020 - 11/2017
2	Pathologic Constriction (Stenosis) 06/2020 - 01/2018
2	Endotoxemia 03/2020 - 12/2017

Drug/Important Bio-Agent (IBA)

13	EndotoxinsIBA 05/2022 - 01/2013
11	Biomarkers (Surrogate Marker)IBA 07/2023 - 09/2017
9	Amino Acids FDA Link 09/2021 - 07/2013
8	von Willebrand FactorIBA 01/2023 - 02/2018
8	CollagenIBA 10/2020 - 12/2008
7	LipopolysaccharidesIBA 01/2022 - 08/2017
7	CDAA (Randox)IBA 12/2021 - 07/2013
7	Choline (Choline Chloride)IBA 03/2020 - 07/2013
6	Aspartate Aminotransferases (Aspartate Transaminase)IBA 07/2023 - 09/2017
6	Angiotensin II Type 1 Receptor BlockersIBA 01/2022 - 02/2016
6	Losartan (Cozaar)FDA LinkGeneric 01/2022 - 11/2017
5	ZincIBA 07/2023 - 06/2021
5	EnzymesIBA 04/2022 - 11/2013
5	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2022 - 02/2016
5	Anti-Bacterial Agents (Antibiotics)IBA 12/2021 - 05/2013
5	CytokinesIBA 06/2021 - 01/2013
5	Glucose (Dextrose)FDA LinkGeneric 03/2020 - 11/2017
4	AntigensIBA 01/2023 - 12/2020
4	Toll-Like Receptor 4IBA 01/2022 - 06/2019
4	Rifaximin (L 105)FDA Link 12/2021 - 12/2017
4	Carbon Tetrachloride (Tetrachloromethane)IBA 12/2021 - 12/2008
4	Angiotensin IIIBA 12/2021 - 04/2013
4	Angiotensin Receptor AntagonistsIBA 12/2021 - 10/2014
4	Carrier Proteins (Binding Protein)IBA 10/2021 - 09/2017
4	Prednisolone (Predate)FDA LinkGeneric 01/2021 - 10/2008
4	Glutathione Transferase (Glutathione S-Transferase)IBA 06/2018 - 12/2008
3	SteroidsIBA 10/2023 - 10/2008
3	AlbuminsIBA 10/2022 - 09/2019
3	lenvatinibIBA 10/2022 - 01/2021
3	Tolvaptan FDA Link 05/2022 - 08/2017
3	AmmoniaIBA 03/2022 - 07/2003
3	Bile Acids and Salts (Bile Acids)IBA 01/2022 - 11/2017
3	Ethanol (Ethyl Alcohol)IBA 12/2021 - 09/2007
3	Branched-Chain Amino AcidsIBA 12/2021 - 08/2013
3	Tissue Inhibitor of MetalloproteinasesIBA 10/2021 - 08/2020
3	Hyaluronic Acid (Hyaluronan)IBA 10/2021 - 08/2020
3	Proteins (Proteins, Gene)FDA Link 06/2021 - 10/2018
3	AntioxidantsIBA 06/2021 - 12/2020
3	DiureticsIBA 01/2021 - 08/2017
3	Alanine Transaminase (SGPT)IBA 04/2020 - 09/2017
3	Sorafenib (BAY 43-9006)FDA Link 12/2019 - 10/2014
2	2-mercaptopurineIBA 01/2024 - 10/2023
2	BilirubinIBA 10/2022 - 10/2021
2	Collagen Type III (Type III Collagen)IBA 10/2021 - 08/2020
2	Triglycerides (Triacylglycerol)IBA 09/2021 - 06/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2021 - 06/2020
2	Capsules (Microcapsules)IBA 01/2021 - 01/2017
2	Messenger RNA (mRNA)IBA 01/2021 - 11/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 07/2008
2	Therapeutic UsesIBA 12/2020 - 11/2017
2	Carnitine (L-Carnitine)FDA LinkGeneric 12/2020 - 01/2019
2	procollagen Type III-N-terminal peptide (PIIP)IBA 10/2020 - 08/2020
2	lusutrombopagIBA 09/2020 - 01/2020
2	Antiviral Agents (Antivirals)IBA 08/2020 - 01/2019
2	Insulin (Novolin)FDA Link 04/2020 - 09/2019
2	CanagliflozinIBA 03/2020 - 01/2018

Therapy/Procedure

17	Therapeutics 12/2023 - 10/2008
8	Drug Therapy (Chemotherapy) 10/2023 - 08/2018
6	Oral Administration 01/2021 - 01/2018
3	Intraperitoneal Injections 01/2021 - 01/2019
3	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2009 - 12/2008
3	Transplantation 01/2009 - 12/2008